TKT and neoplasm: High expression of TKT has been demonstrated to promote tumor progression and correlate with poor clinical outcomes [16, 27], whereas TKT ablation upregulates tumor suppressor pathways, suppresses oncometabolite accumulation, and effectively inhibits metastatic dissemination [17, 25, 27, 28], suggesting its potential as a therapeutic target [26, 29–31].